Evidence map›Paper›PMID 36234523›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Possible Synergies of Nanomaterial-Assisted Tissue Regeneration in Plasma Medicine: Mechanisms and Safety Concerns.

Priyanka Shaw, Patrick Vanraes, Naresh Kumar, Annemie Bogaerts

Abstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Priyanka ShawResearch Group PLASMANT, Department of Chemistry, University of Antwerp, 2610 Antwerp, Belgium.ORCID 0000-0002-8682-1592
Patrick VanraesResearch Group PLASMANT, Department of Chemistry, University of Antwerp, 2610 Antwerp, Belgium.
Naresh KumarDepartment of Medical Devices, National Institute of Pharmaceutical Education and Research, Guwahati 781125, Assam, India.ORCID 0000-0003-4682-3371
Annemie BogaertsResearch Group PLASMANT, Department of Chemistry, University of Antwerp, 2610 Antwerp, Belgium.ORCID 0000-0001-9875-6460

Funding

Department of Biotechnology (DBT) Ramalingaswami Re-entry Fellowship BT/RLF/Re-entry/27/2019Department of Science and Technology, Science and Engineering Research Board (SERB), Core Research Grant, India CRG/2021/001935
6 · The paper itself

Abstract

Cold atmospheric plasma and nanomedicine originally emerged as individual domains, but are increasingly applied in combination with each other. Most research is performed in the context of cancer treatment, with only little focus yet on the possible synergies. Many questions remain on the potential of this promising hybrid technology, particularly regarding regenerative medicine and tissue engineering. In this perspective article, we therefore start from the fundamental mechanisms in the individual technologies, in order to envision possible synergies for wound healing and tissue recovery, as well as research strategies to discover and optimize them. Among these strategies, we demonstrate how cold plasmas and nanomaterials can enhance each other's strengths and overcome each other's limitations. The parallels with cancer research, biotechnology and plasma surface modification further serve as inspiration for the envisioned synergies in tissue regeneration. The discovery and optimization of synergies may also be realized based on a profound understanding of the underlying redox- and field-related biological processes. Finally, we emphasize the toxicity concerns in plasma and nanomedicine, which may be partly remediated by their combination, but also partly amplified. A widespread use of standardized protocols and materials is therefore strongly recommended, to ensure both a fast and safe clinical implementation.

Indexed as

endogenous electric fieldsnanotoxicityplasma medicinepulsed electric fieldreactive nitrogen speciesreactive oxygen species

Identifiers

PMID36234523
PMCPMC9565759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.